Robert E. Wanerman, JD, MPH

Epstein Becker Green

Rob Wanerman is a health care regulatory attorney at Epstein Becker Green in Washington, DC. His clients include biotech companies, medical device manufacturers, diagnostics manufacturers and suppliers, companies integrating artificial intelligence into diagnostics and treatments, Medicare and Medicaid providers (hospitals, home health, hospice), precision medicine/genomics companies, and health care startups.

Rob has extensive experience advising innovators on coverage, coding, and reimbursement for new technologies and related procedures, as well as on general compliance with health care laws. Clients also rely on Rob for advice on matters arising under the False Claims Act, clinical research rules, grant administration rules, the Anti-Kickback Statute, the Stark Law, HIPAA, and EMTALA. In addition, Rob represents clients in government audits, investigations, litigation, and appeals involving the Medicare and Medicaid programs.

Rob is a graduate of The University of Chicago, New York Law School, and the Columbia University School of Public Health. He writes and lectures frequently on health care regulations and innovation, and is a member of the editorial advisory board of the Journal of Commercial Biotechnology. This is his 10th presentation at the Biotechnology Entrepreneurship Boot Camp.